Tumor mutation burden-assisted risk stratification for papillary thyroid cancer.
Zhijiang ChenWeiran WangJiajie XuYuntao SongHonglin ZhuTonghui MaMinghua GeHaixia GuanPublished in: Endocrine (2022)
The presence of BRAF V600E and/or TERT promoter mutations denotes a high risk of recurrence in TMB-H patients. This represents a powerful molecular prognostic genotype that can help predict patients with the highest risk of recurrence.